Long-Term Monitoring of Individuals With Chronic Obstructive Pulmonary Disease Using Digital Health Technology: Qualitative Study

被引:0
|
作者
Chien, Shih-Ying [1 ,2 ,3 ]
Hu, Han-Chung [4 ,5 ]
Cho, Hsiu-Ying [5 ]
机构
[1] Chang Gung Univ, Dept Ind Design, 259,Wen Hwa 1st Rd, Taoyuan 333, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Publ Hlth & Med Humanities, Hsinchu, Taiwan
[3] Linkou Chang Gung Mem Hosp CGMH, Dept Phys Med & Rehabil, Taoyuan, Taiwan
[4] Linkou Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan
[5] Linkou Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan
关键词
digital health; chronic obstructive pulmonary disease; digital health technology; barriers and facilitators; Taiwan; OF-LIFE; REHABILITATION; HOSPITALIZATION; HYPERINFLATION; INTERVENTIONS; EXACERBATION; BARRIERS; OUTCOMES; DYSPNEA;
D O I
10.2196/63660
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Digital health adoption in clinical practice has been widespread, yet there remains further potential for optimizing care specifically for chronic obstructive pulmonary disease (COPD). This study therefore conducted qualitative research involving 35 health care professionals from a range of hospitals in Taiwan. Objective: This study aims to investigate barriers and facilitators related to the implementation of digital health technology (DHT) in the long-term monitoring of individuals with COPD based on clinical experiences in Taiwan. The perspectives of Taiwanese health care professionals provided valuable insights into the challenges and opportunities associated with using DHT for the management and enhancement of respiratory rehabilitation and long-term monitoring of patients with COPD. Methods: Several key themes related to the development of DHT were identified. Barriers encompassed concerns pertaining to digital safety, insurance coverage, constraints related to medical resources, and the presence of a digital divide. Facilitators included the potential for cost reduction, personalized prescriptions, and instilling motivation in users. Results: To enhance the acceptance and use of DHT, embracing a user-centered approach that prioritizes the distinct needs of all parties involved is recommended. Moreover, optimizing and leveraging the effective use of DHT in managing the health of individuals with COPD promises to deliver care characterized by greater precision and efficiency. Conclusions: Overall, the benefits of using DHT for the long-term care of patients with COPD outweigh the disadvantages. After the COVID-19 pandemic, there has been an increased emphasis in Taiwan on the effectiveness of DHT in managing chronic diseases. Relevant studies including this paper have suggested that web-based exercise management systems could benefit patients with COPD in rehabilitation and tracking. Our findings provide meaningful directions for future research endeavors and practical implementation. By addressing identified barriers and capitalizing on facilitators, advancements can be made in the development and use of DHT, especially in overcoming challenges such as information security and operational methods. The implementation of the recommended strategies will likely lead to improved COPD care outcomes.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease
    Sin, DD
    Man, SFP
    DRUGS & AGING, 2003, 20 (12) : 867 - 880
  • [42] LONG-TERM OXYGEN-THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    RUHLE, KH
    KLEIN, G
    MATTYS, H
    MEDIZINISCHE KLINIK, 1986, 81 (09) : 311 - 315
  • [43] European guidelines on noninvasive long-term ventilation for chronic obstructive pulmonary disease
    Wollsching-Strobel, M.
    Windisch, W.
    Majorski, D. S.
    PNEUMOLOGE, 2021, 18 (01): : 13 - 19
  • [44] LONG-TERM PROGNOSIS OF POLYVASCULAR PATIENTS WITH ASSOCIATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Manea, Paloma
    Ghiuru, Rodica
    Gavrilescu, Maria Cristina
    Munteanu, D.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (03): : 669 - 673
  • [45] Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease
    Seo, Minseok
    Qiu, Weiliang
    Bailey, William
    Criner, Gerard J.
    Dransfield, Mark T.
    Fuhlbrigge, Anne L.
    Reilly, John J.
    Scholand, Mary Beth
    Castaldi, Peter
    Chase, Robert
    Parker, Margaret
    Saferali, Aabida
    Yun, Jeong H.
    Crapo, James D.
    Cho, Michael H.
    Beaty, Terri H.
    Silverman, Edwin K.
    Hersh, Craig P.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (12): : 1375 - 1385
  • [46] A Home Remote Mobile Monitoring System for Long-term Oxygen Therapy for Chronic Obstructive Pulmonary Disease Management
    Dijemeni, Esuabom
    Lund-Palau, Helena
    Mloduchowski, Tomasz
    Liang, Shun
    Nzekwu, Cherry
    2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB), 2015,
  • [47] Digital tomosynthesis in diagnostics and monitoring of chronic obstructive pulmonary disease
    Nalivaico, Nicolae
    Moscovciuc, Anna
    Sincarenco, Irina
    Bolotnicova, Valentina
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] Living with chronic obstructive pulmonary disease: a qualitative study
    Avsar, Gulcin
    Kasikci, Magfiret
    AUSTRALIAN JOURNAL OF ADVANCED NURSING, 2010, 28 (02) : 46 - 52
  • [49] UTILIZATION OF HEALTH INFORMATION TECHNOLOGY AND PNEUMOCOCCAL VACCINATION AMONG INDIVIDUALS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Yeboah-Kordieh, Yvette
    Rajesh, Samuel T.
    Ampaw, Nana Yaa
    Haas, Chris
    CHEST, 2024, 166 (04) : 4690A - 4690A
  • [50] LONG-TERM COURSE OF PULMONARY ARTERIAL-PRESSURE IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    WEITZENBLUM, E
    SAUTEGEAU, A
    EHRHART, M
    MAMMOSSER, M
    HIRTH, C
    ROEGEL, E
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 130 (06): : 993 - 998